Deciphering the hidden code by Epigenetic and Epigenomic Analysis

We all know that the primary cause of cancer is genetic mutations. And at some point, we all might have thought, why can’t we just repair the mutated gene to cure cancer? But sometimes the sequence of the gene isn’t mutated for it to go wild and cause cancer. The promoter region of any gene is heavily regulated by chemical compounds which is not part of the DNA sequence and are not heritable but do play a significant role in the regulation of gene expression. The study of heritable changes in gene expression and cellular phenotype without alterations to the underlying DNA sequence is known as Epigenetics. Epigenetic changes are not inherited by the progeny but they can be passed from one generation of cells to the next during cell division, allowing the transmission of epigenetic information. Epigenetic modifications are reversible and responsive to environmental cues, making them essential in adapting to changing conditions.

Chromosomes and chromatin

Chromosomes present in the nucleus comprise chromatin, which is made of DNA, RNA, and associated proteins. The chromatin controls DNA replication and gene expression, gives support to DNA, prevents DNA damage, and tightly packs DNA so that it can fit into the nucleus. Two kinds of chromatin can be seen in chromosomes, such as euchromatin, which has a less compact structure, and heterochromatin, which is more compact and tightly bound. Transcription of DNA takes place only in euchromatin. Epigenetic modifications alter chromatin structure. Epigenetic modifications include DNA methylation, histone modifications, and non-coding RNA molecules. DNA methylation involves the addition of methyl groups to cytosine residues, which is typically associated with gene silencing. Histone modifications, such as acetylation and methylation, alter chromatin structure and gene accessibility.

Epigenetics and Epigenomics

Epigenetics is concerned with the mechanisms that govern the activation and deactivation of specific genes, controlling when they are active or inactive. In contrast, epigenomics involves the study of epigenetic modifications that occur across numerous genes within a cell or the entire organism. Epigenomic analysis involves studying chromatin modifications on a genome-wide scale, offering profound insights into development, disease, and evolution.

https://www.shutterstock.com/image-vector/epigenetic-mechanisms-dna-acid-gene-protein-1972409909

Methods developed to study epigenetics

There are several methods that have been developed to study epigenetics, such as bisulfite sequencing, high-resolution melt analysis, methylated DNA immunoprecipitation (MeDIP), ChIP-seq, ATAC-seq, RNA-seq, and small RNA-seq.

Bisulfite sequencing: In bisulfite sequencing, sodium bisulfite converts unmethylated cytosines to uracil, enabling the differentiation between methylated and unmethylated DNA, as methylated cytosines cannot be converted.

https://upload.wikimedia.org/wikipedia/commons/thumb/b/bc/Bisulfite_conversion.svg/1920px-Bisulfite_conversion.svg.png

MeDIP: MeDIP uses antibodies to enrich and isolate methylated DNA, followed by sequencing or microarray analysis. This technique can be used to examine changes in DNA patterns in the whole genome.

ChIP-Seq: ChIP-Seq (Chromatin Immunoprecipitation Sequencing) is a powerful molecular biology technique used to investigate protein-DNA interactions within a cell. It begins by cross-linking proteins to DNA, followed by DNA fragmentation and immunoprecipitation of the protein of interest. After purification, the DNA fragments are sequenced, allowing researchers to pinpoint regions where the protein binds to the genome. ChIP-Seq is crucial in understanding gene regulation, identifying transcription factor binding sites, and studying epigenetic modifications.

ATAC-Seq: ATAC-Seq (Assay for Transposase-Accessible Chromatin Sequencing) is an epigenomics technique that examines chromatin accessibility across the genome. It begins by exposing cells to a hyperactive transposase enzyme, which selectively inserts sequencing adapters into open chromatin regions. After DNA purification and sequencing, ATAC-Seq generates valuable information about regions of open chromatin, transcription factor binding sites, and nucleosome positioning. This technique provides insights into gene regulation, identifying regulatory elements and potential disease-associated variants. ATAC-Seq's speed, low input requirements, and high sensitivity make it an indispensable tool for understanding the dynamic landscape of chromatin accessibility in diverse biological contexts.

RNA-Seq: RNA-Seq allows comprehensive profiling of the entire transcriptome. By sequencing RNA molecules within a biological sample, it provides insights into gene expression, alternative splicing, and non-coding RNA abundance. RNA-Seq is pivotal in various fields, from understanding disease mechanisms and drug discovery to exploring the intricacies of developmental biology. It offers quantitative data with high accuracy, enabling researchers to identify differentially expressed genes, discover novel transcripts, and uncover regulatory networks. The small RNA-Seq method focuses on small RNA molecules, including microRNAs and small interfering RNAs, which play a role in epigenetic regulation.

Application of Epigenomic analysis

Epigenetic and epigenomic analysis is applied in various fields of medicine, such as cancer research, neurobiology, ageing and longevity, and many more.

• Epigenetic alterations are a hallmark of cancer, and epigenomic analysis helps identify potential therapeutic targets and predict patient outcomes. DNA methylation patterns can distinguish between cancer types and provide insights into tumour progression.
• Epigenetic modifications regulate cell differentiation and tissue-specific gene expression during development. Understanding these processes is crucial for regenerative medicine and stem cell therapies.
• Furthermore, epigenomic analysis in neuroscience explores the role of epigenetics in neurodevelopment, neurodegenerative diseases, and mental health disorders.
• Epigenetic changes can influence learning, memory, and synaptic plasticity. Epigenetic clocks, based on DNA methylation patterns, can estimate biological age and predict age-related diseases.
• Environmental factors, such as diet, stress, and exposure to toxins, can induce epigenetic changes with lasting health effects.
• Epigenomic analysis helps uncover how the environment interacts with genetics.

Scientists are facing some challenges in epigenetic and epigenomic analysis. Epigenomic datasets are large and complex, requiring advanced computational tools and expertise for analysis. Tissues are composed of various cell types with distinct epigenomic profiles, making it challenging to interpret results from mixed samples. Also, identifying causative epigenetic changes versus mere correlations with disease remains a challenge. Variability in sample preparation and sequencing technologies can introduce biases and affect reproducibility.

Conclusion

Epigenetic and epigenomic analysis have opened new frontiers in biology and medicine, unveiling the intricate regulatory mechanisms that govern gene expression and cellular identity. From cancer diagnostics to developmental biology and ageing research, epigenomics is transforming our understanding of life's complexity. As technology continues to evolve and our knowledge deepens, the potential for targeted therapies and personalised medicine driven by epigenetic insights is boundless. Epigenetics is not only reshaping biology but also offering hope for a healthier future.

MD: With the help of various sequencing techniques, unlocking and identifying the genetic code by epigenetic and epigenomic landscapes for better understanding and working of our genome.